Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
286
-
Total 13F shares, excl. options
-
40.5M
-
Shares change
-
-512K
-
Total reported value, excl. options
-
$3.23B
-
Value change
-
-$40M
-
Put/Call ratio
-
0.92
-
Number of buys
-
113
-
Number of sells
-
-173
-
Price
-
$79.75
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q3 2019
360 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q3 2019.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 286 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.5M shares
of 44.8M outstanding shares and own 90.36% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.42M shares), VANGUARD GROUP INC (3.9M shares), RENAISSANCE TECHNOLOGIES LLC (3.21M shares), FMR LLC (2.18M shares), STATE STREET CORP (1.88M shares), MILLENNIUM MANAGEMENT LLC (1.68M shares), CITADEL ADVISORS LLC (1.46M shares), Palo Alto Investors LP (1.42M shares), Consonance Capital Management LP (968K shares), and D. E. Shaw & Co., Inc. (914K shares).
This table shows the top 286 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.